Insufficient scRNA-seq data for expression of PAEP at single-cell level.
Insufficient scRNA-seq data for expression of PAEP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 68% | 34.52 | 1237 / 1809 | 50% | 442.82 | 237 / 472 |
ovary | 32% | 32.69 | 58 / 180 | 68% | 46.09 | 293 / 430 |
lung | 32% | 8.20 | 187 / 578 | 40% | 88.89 | 457 / 1155 |
uterus | 30% | 424.38 | 51 / 170 | 15% | 12.89 | 71 / 459 |
breast | 28% | 7.36 | 127 / 459 | 9% | 1.52 | 101 / 1118 |
pancreas | 0% | 0.02 | 1 / 328 | 32% | 12.46 | 57 / 178 |
eye | 0% | 0 | 0 / 0 | 31% | 3.93 | 25 / 80 |
bladder | 14% | 3.38 | 3 / 21 | 14% | 11.35 | 73 / 504 |
liver | 4% | 3.07 | 10 / 226 | 22% | 33.36 | 89 / 406 |
prostate | 20% | 87.43 | 50 / 245 | 2% | 0.17 | 9 / 502 |
esophagus | 1% | 0.22 | 17 / 1445 | 19% | 2.12 | 34 / 183 |
stomach | 2% | 0.25 | 6 / 359 | 15% | 33.88 | 44 / 286 |
intestine | 3% | 0.28 | 30 / 966 | 12% | 1.55 | 61 / 527 |
spleen | 13% | 1.94 | 32 / 241 | 0% | 0 | 0 / 0 |
adipose | 13% | 3.37 | 156 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 12% | 13.81 | 111 / 901 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.28 | 3 / 45 |
adrenal gland | 2% | 0.22 | 4 / 258 | 2% | 0.92 | 5 / 230 |
thymus | 3% | 0.40 | 21 / 653 | 0% | 0.01 | 3 / 605 |
blood vessel | 3% | 0.83 | 45 / 1335 | 0% | 0 | 0 / 0 |
heart | 3% | 0.62 | 26 / 861 | 0% | 0 | 0 / 0 |
brain | 2% | 0.42 | 49 / 2642 | 1% | 0.42 | 6 / 705 |
peripheral blood | 1% | 0.21 | 9 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.01 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000359 | Biological process | regulation of binding of sperm to zona pellucida |
GO_0006915 | Biological process | apoptotic process |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_1902491 | Biological process | negative regulation of sperm capacitation |
GO_0005576 | Cellular component | extracellular region |
GO_0005515 | Molecular function | protein binding |
GO_0036094 | Molecular function | small molecule binding |
Gene name | PAEP |
Protein name | Glycodelin (GD) (Placental protein 14) (PP14) (Pregnancy-associated endometrial alpha-2 globulin) (PAEG) (PEG) (Progestagen-associated endometrial protein) (Progesterone-associated endometrial protein) (Zona-binding inhibitory factor-1) (ZIF-1) Progestagen associated endometrial protein Glycodelin (Progestagen associated endometrial protein) |
Synonyms | |
Description | FUNCTION: Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities . Glycodelin-C stimulates binding of spermatozoa to the zona pellucida . Glycodelin-F inhibits spermatozoa-zona pellucida binding and significantly suppresses progesterone-induced acrosome reaction of spermatozoa . Glycodelin-S in seminal plasma maintains the uncapacitated state of human spermatozoa . . |
Accessions | ENST00000371768.7 H0Y530 ENST00000418284.5 A6XNE0 ENST00000371766.6 [P09466-1] H0Y4U4 F2Z349 ENST00000433563.5 H0Y6A4 ENST00000454923.5 Q5T6T6 ENST00000611414.4 ENST00000277508.9 [P09466-1] ENST00000457014.1 P09466 ENST00000479141.6 [P09466-1] |